Your browser doesn't support javascript.
loading
Emerging roles of RNA ac4C modification and NAT10 in mammalian development and human diseases.
Zhang, Yigan; Lei, Yumei; Dong, Yanbin; Chen, Shuwen; Sun, Siyuan; Zhou, Fange; Zhao, Zhiwen; Chen, Bonan; Wei, Lv; Chen, Juan; Meng, Zhongji.
Affiliation
  • Zhang Y; Institute of Biomedical Research, Department of Infectious Diseases, Regulatory Mechanism and Targeted Therapy for Liver Cancer Shiyan Key Laboratory, Hubei rovincial Clinical Research Center for Precise Diagnosis and Treatment of Liver Cancer, Taihe Hospital, Hubei University of Medicine, Shiyan, H
  • Lei Y; Key Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Health, China Agricultural University, Beijing, China.
  • Dong Y; Institute of Biophysics, Chinese Academy of Sciences, Key Laboratory of Nucleic Acid Biology, Chinese Academy of Sciences, Beijing, China.
  • Chen S; School of Biomedical Engineering, Hubei University of Medicine, Shiyan, China.
  • Sun S; Key Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Health, China Agricultural University, Beijing, China.
  • Zhou F; The First Clinical School of Hubei University of Medicine, Shiyan, China.
  • Zhao Z; Department of Emergency Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
  • Chen B; Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.
  • Wei L; Institute of Biophysics, Chinese Academy of Sciences, Key Laboratory of Nucleic Acid Biology, Chinese Academy of Sciences, Beijing, China. Electronic address: green1112@ibp.ac.cn.
  • Chen J; Key Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Health, China Agricultural University, Beijing, China. Electronic address: chenjuan@cau.edu.cn.
  • Meng Z; Institute of Biomedical Research, Department of Infectious Diseases, Regulatory Mechanism and Targeted Therapy for Liver Cancer Shiyan Key Laboratory, Hubei rovincial Clinical Research Center for Precise Diagnosis and Treatment of Liver Cancer, Taihe Hospital, Hubei University of Medicine, Shiyan, H
Pharmacol Ther ; 253: 108576, 2024 Jan.
Article in En | MEDLINE | ID: mdl-38065232
ABSTRACT
RNA ac4C modification is a novel and rare chemical modification observed in mRNA. Traditional biochemical studies had primarily associated ac4C modification with tRNA and rRNA until in 2018, Arango D et al. first reported the presence of ac4C modification on mRNA and demonstrated its critical role in mRNA stability and translation regulation. Furthermore, they established that the ac4C modification on mRNA is mediated by the classical N-acetyltransferase NAT10. Subsequent studies have underscored the essential implications of NAT10 and mRNA ac4C modification across both physiological and pathological regulatory processes. In this review, we aimed to explore the discovery history of RNA ac4C modification, its detection methods, and its regulatory mechanisms in disease and physiological development. We offer a forward-looking examination and discourse concerning the employment of RNA ac4C modification as a prospective therapeutic strategy across diverse diseases. Furthermore, we comprehensively summarize the functions and mechanisms of NAT10 in gene expression regulation and pathogenesis independent of RNA ac4C modification.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: N-Terminal Acetyltransferases / Mammals Limits: Animals / Humans Language: En Journal: Pharmacol Ther Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: N-Terminal Acetyltransferases / Mammals Limits: Animals / Humans Language: En Journal: Pharmacol Ther Year: 2024 Document type: Article